A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 445 participants.
Also called NCT03998319
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose other
- Phase
- Phase 3
- Enrolled
- 445 participants
- Sponsor
- Registry
-
NCT03998319
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, New Zealand
- Registry status
- Recruiting
Technical summary
Registry record NCT03998319. Randomized; quadruple masking; primary purpose other. Start 2021-10-14 (actual); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
- Acronym
- RESTORE-MI
- Condition
- STEMI
- Condition
- Elevated IMR (>32)
- Intervention (Drug)
- Tenecteplase (1/3 systemic weight based dose)
- Intervention (Other)
- Sterile water for injection (WFI)
- Lead sponsor
- University of Sydney
Record details
- Record id
cardio:ct-nct03998319- Content hash
8da30157beab1e0d23f988c2f5d803e3ac02c78887c3af015a16f28db91aa519